TradingMethods
@Trading_Methods
Investitore dilettante - Amateur trader 🏴
You might like
Co-Authorship Networks of this year's Nobel Prize Winners in Medicine, Physics, and Chemistry. 🤩
My question for those who liked $JD at $35, why don’t you like it now at $31? 🤔 Same company, same fundamentals, nothing has changed. Another early Christmas gift 🎁 Price target: $73.50 #JD #Stocks
$BULL the borrowing fee rate is now at 195% …. meaning the daily fee is roughly 195% ÷ 365 ≈ 0.534% of the stock’s value per day. For example, if you short $10,000 worth of stock, the daily borrow fee would be about $53.40. A 195% annualized rate is astronomical, making it…
It's been a while since I've seen spirits sales increase. Way to go everyone! 🙌 $BF $DEO
$DEO looks great here on the monthly time frame, currently trading at a huge pivot @ $93. -58% from all time highs🔴📉 Financials are rock solid, consistent revenue, profits, & free cash flow💰
$JD - Mean reversion to 31 over and we have confirmation on Weekly charts. Saral will initiate a options trade for Jan expiry. Subscribe for details..!
$BULL - confirmation on Weekly charts. Saral has added some options spreads..!
$BULL - Positional trade confirmation...this will have targets of $20 and 22...!
$BULL #WEBULL Daily. What a head turning move today. Essentially working to make a right inverted shoulder Rose above falling wedge and tried to settle above it. I wouldn’t be surprised if it makes it to 17 level next wk. then possibly pullback to retest the wedge roof…
$BULL #Webull Daily update 👇 Tapped 14.74 and rejected twice from that OB zone which was expected. Now it may take a breathing route to sub 13 at the bullish OB zone before going higher. Note: 12.54 is a swing low. If it breaks down then the trend turns bearish and 12 and…
$BULL - Anyone else notice the big volume spike today? 👀👀
$NVO Pakistan led a healthcare delegation to Copenhagen to share knowledge on tackling diabetes & obesity. With 34.5M people living with diabetes and 38M with obesity in Pakistan, the program focused on early interventions, better care & adapting Denmark’s innovations to local…
$BULL Let’s ride this beautiful setup. 🤝🏻
Eventually this range will break to the upside for $BULL when the market conditions are right. I started adding shares again today for a MT/LT swing. It's currently in an accumulation range from $10 to $18. This could be a massive winner into early 2026.
$NVO is one step away from EU approval for its new diabetes drug Kyinsu. It combines Ozempic’s active ingredient (semaglutide) with a once-weekly insulin (Awiqli). EMA has recommended approval, now it just needs the EU Commission’s final sign-off. #stocks #investing
The $PYPL ads team are expanding offerings to the UK and Germany now with transaction based advertising. Will be interested to see how this interfaces within transactions. Will report on any on my end 🤝🏻
$PYPL Offsite ads launch in the UK and Germany for PayPal. Advertisers can also run advertising campaigns "in the coming months."
Updated 13F from Morgan Stanley. HUGE increase and now the #1 institutional holder. 👀 $smlr
$NVO ’s R&D chief Martin Holst Lange says cagrilintide may appeal to patients seeking moderate weight loss with fewer side effects. Average loss was ~12% at 68 weeks, and gastrointestinal issues were about half of what Novo typically sees with GLP-1s. He added that Novo wants a…
$NVO shared new data on its next-generation obesity drug cagrilintide. Patients lost an average of 12.5kg (≈11.8% of body weight) after 68 weeks, compared with just 2.5kg on placebo. About 1 in 3 people achieved 15%+ weight loss. The drug was generally well tolerated, with…
$NVO ’s INFORM survey suggests Wegovy delivers more than weight loss. • 46% fewer people reported constant “food noise” (intrusive food thoughts) • 64% said mental health improved • 80% developed healthier habits • 83% were satisfied with treatment Link to press release:…
$NVO just got EU approval for Rybelsus (oral semaglutide) to show heart benefits in type 2 diabetes. It’s now the first and only oral GLP-1 in Europe proven to cut the risk of heart attack, stroke, and cardiovascular death. The approval is based on the SOUL trial, where…
Oggi parliamo di un altro episodio di "Fidati degli esperti" in ambito scientifico. Marzo 2019. Una grande multinazionale americana decide di stoppare due grandi studi sull' Alzheimer perchè dalla stessa ritenuti inutili, 👇
United States Trends
- 1. Ace Frehley 14.3K posts
- 2. John Bolton 88.9K posts
- 3. #NationalBreadDay 1,755 posts
- 4. Ashby 1,667 posts
- 5. Asheville 6,891 posts
- 6. Glasnow 2,154 posts
- 7. RIP Spaceman N/A
- 8. Steelers 27.5K posts
- 9. Putin 191K posts
- 10. Space Ace N/A
- 11. Mitch McConnell 42.3K posts
- 12. Jake Bauers N/A
- 13. #KonamiWorldSeriesSweepstakes 2,115 posts
- 14. Curt Cignetti 6,374 posts
- 15. Term 202K posts
- 16. Muncy 2,552 posts
- 17. Smartmatic 5,570 posts
- 18. Andrade 12.6K posts
- 19. Espionage Act 14.5K posts
- 20. Jacob Misiorowski N/A
Something went wrong.
Something went wrong.